Guest guest Posted October 7, 2006 Report Share Posted October 7, 2006 16% of drug-naive entering GSK US studies already have resistance Sixteen per cent of treatment-naïve patients enrolling in Glaxo Kline-sponsored clinical trials in the United States in 2005 already had resistance to at least one antiretroviral drug, according to data presented by company researchers at the Forty-Sixth Interscience Conference on Antimicrobial Agents and Chemotherapy in San Francisco on Thursday. Read More >> Regards, Vergelpowerusa dot org"Act with a determination not to be turned aside by thoughts of the past and fears of the future."- E. Lee Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.